...
首页> 外文期刊>RSC Advances >Biomimetic hollow mesoporous hydroxyapatite microsphere with controlled morphology, entrapment efficiency and degradability for cancer therapy
【24h】

Biomimetic hollow mesoporous hydroxyapatite microsphere with controlled morphology, entrapment efficiency and degradability for cancer therapy

机译:染色中空中空羟基磷灰石微球,具有受控形态,熵效率和癌症治疗可降解性

获取原文
获取原文并翻译 | 示例

摘要

Hollow hydroxyapatite (HAp) microspheres bearing hierarchical structures have been one of the most popular carriers for drug delivery. However, it's been challenging to find an approach that can simultaneously control the morphology, degradability and drug loading/releasing properties of the microsphere. In this study, hollow mesoporous microspheres composed of nano-sized HAp crystals were hydrothermally synthesized from hollow CaCO3 precursors prepared via sodium dodecyl sulfate (SDS)-assisted precipitation. The particle size, hollow structure and wall thickness of the fabricated hollow mesoporous carbonated HAp microsphere (CHAM) could be facilely regulated by tailoring the concentration of SDS in the reaction. The achieved carbonate-containing CHAMs were demonstrated to be suitable for drug delivery through either surface attachment or intracellular engulfment without causing cytotoxicity. In addition, their distinguished biodegradability and sustained drug release properties in a pH-dependent manner might allow them to be used in cancer treatment by targeting the acidic microenvironment in a solid tumor. Moreover, the CHAM prepared using SDS at its critical micelle concentration (CMC) was suggested to be optimal for anti-cancer therapy due to its highest entrapment efficiency of cis-diammineplatinum(II) dichloride (CDDP) and the strongest killing effect on human squamous cell carcinoma in vitro.
机译:空心羟基磷灰石(HAP)微球轴承层次结构一直是最流行的载体药物传递的一个。然而,它具有挑战性找到了一种方法,可以同时控制形态,降解性和载药量/释放微球的特性。在这项研究中,纳米尺寸的HAp结晶构成的中空孔的微球水热从空心碳酸钙的前体合成的制备通过十二烷基硫酸钠(SDS)辅助沉淀。颗粒尺寸,中空结构和所制造的中空介孔碳酸羟基磷灰石微球(CHAM)的壁厚可以通过在反应剪裁SDS的浓度来调节轻便。所获得的含有碳酸盐的占人被证明是适合于通过任一表面附着或细胞内吞噬且不产生细胞毒性的药物递送。此外,以pH依赖性的方式其可分辨的生物降解性和持续的药物释放特性可能允许它们在癌症治疗中在固体肿瘤靶向酸性微环境中使用。此外,使用在其临界胶束浓度(CMC)SDS建议成为抗癌治疗最佳制备由于其最高包封率湛顺 - 二氨基铂(II)二氯化物(CDDP)和对人类鳞状最强的杀伤作用体外细胞癌。

著录项

  • 来源
    《RSC Advances 》 |2017年第71期| 共11页
  • 作者单位

    Univ Hong Kong Dent Mat Sci Appl Oral Sci Fac Dent Prince Philip Dent Hosp Rm 1F30 1-F 34 Hosp Rd Sai Ying Pun Hong Kong Peoples R China;

    Univ Hong Kong Dept Oral &

    Maxillofacial Surg Fac Dent Prince Philip Dent Hosp Rm 2B88 2-F 34 Hosp Rd Sai Ying Pun Hong Kong Peoples R China;

    Univ Hong Kong Dent Mat Sci Appl Oral Sci Fac Dent Prince Philip Dent Hosp Rm 1F30 1-F 34 Hosp Rd Sai Ying Pun Hong Kong Peoples R China;

    Sun Yat Sen Univ Inst Stomatol Res Guanghua Sch Stomatol Hosp Stomatol Dept Oral Implantol Guangzhou Guangdong Peoples R China;

    Univ Hong Kong Dept Oral &

    Maxillofacial Surg Fac Dent Prince Philip Dent Hosp Rm 2B88 2-F 34 Hosp Rd Sai Ying Pun Hong Kong Peoples R China;

    Univ Hong Kong Queen Mary Hosp Li Ka Shing Fac Med Dept Orthopaed &

    Traumatol Queen Mary Hosp Rm 515 5-F Professorial Block 102 Pokfulam Rd Hong Kong Hong Kong Peoples R China;

    Univ Hong Kong Dent Mat Sci Appl Oral Sci Fac Dent Prince Philip Dent Hosp Rm 1F30 1-F 34 Hosp Rd Sai Ying Pun Hong Kong Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 化学 ;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号